ID

31974

Beschreibung

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care; ODM derived from: https://clinicaltrials.gov/show/NCT01163916

Link

https://clinicaltrials.gov/show/NCT01163916

Stichworte

  1. 09.10.18 09.10.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

9. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Rheumatoid Arthritis NCT01163916

Eligibility Rheumatoid Arthritis NCT01163916

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients for whom adalimumab therapy is indicated according to product label and who meet the following criteria:
Beschreibung

Indication Adalimumab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1122087
patients who are newly prescribed adalimumab therapy (no prior history of treatment with adalimumab) including patients with infliximab treatment history.
Beschreibung

Adalimumab prescribed newly | infliximab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1122087
UMLS CUI [1,2]
C0278329
UMLS CUI [1,3]
C0750546
UMLS CUI [2]
C0666743
patients who completed abbott sponsored interventional trials and are continuing treatment with commercial adalimumab thereafter.
Beschreibung

Clinical Trials Specified Completed | adalimumab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
UMLS CUI [1,3]
C0205197
UMLS CUI [2]
C1122087
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
the following patients will not be included in the study:
Beschreibung

Patients Excluded

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332196
patients who are being treated or will be treated with drugs at risk of interactions with adalimumab.
Beschreibung

Pharmaceutical Preparations At risk Interactions Adalimumab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0687133
UMLS CUI [1,4]
C1122087
hypersensitivity to adalimumab
Beschreibung

Hypersensitivity Adalimumab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1122087
pregnancy
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
lactation
Beschreibung

Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
age below 18
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
infectious diseases including tuberculosis
Beschreibung

Communicable Diseases | Tuberculosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0041296
patients currently participating in another clinical trial.
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568

Ähnliche Modelle

Eligibility Rheumatoid Arthritis NCT01163916

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Indication Adalimumab
Item
patients for whom adalimumab therapy is indicated according to product label and who meet the following criteria:
boolean
C3146298 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
Adalimumab prescribed newly | infliximab
Item
patients who are newly prescribed adalimumab therapy (no prior history of treatment with adalimumab) including patients with infliximab treatment history.
boolean
C1122087 (UMLS CUI [1,1])
C0278329 (UMLS CUI [1,2])
C0750546 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
Clinical Trials Specified Completed | adalimumab
Item
patients who completed abbott sponsored interventional trials and are continuing treatment with commercial adalimumab thereafter.
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C1122087 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Patients Excluded
Item
the following patients will not be included in the study:
boolean
C0030705 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
Pharmaceutical Preparations At risk Interactions Adalimumab
Item
patients who are being treated or will be treated with drugs at risk of interactions with adalimumab.
boolean
C0013227 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0687133 (UMLS CUI [1,3])
C1122087 (UMLS CUI [1,4])
Hypersensitivity Adalimumab
Item
hypersensitivity to adalimumab
boolean
C0020517 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Breast Feeding
Item
lactation
boolean
C0006147 (UMLS CUI [1])
Age
Item
age below 18
boolean
C0001779 (UMLS CUI [1])
Communicable Diseases | Tuberculosis
Item
infectious diseases including tuberculosis
boolean
C0009450 (UMLS CUI [1])
C0041296 (UMLS CUI [2])
Study Subject Participation Status
Item
patients currently participating in another clinical trial.
boolean
C2348568 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video